BackOrphazyme A/S Overview

Orphazyme A/S Current Cash

Latest current cash for ORPH: $14M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$13.97M
53.95% YoYΔ $-16.37M vs prior year quarter

Peer trimmed avg / median

Loading

Orphazyme A/S Current Cash History

Loading

Orphazyme A/S vs. peers: Current Cash Comparison

Loading

Orphazyme A/S Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orphazyme A/S (ORPH) FAQ

As of the most recent data (June 2024), ORPH shows a current cash of $14M. That compares with $30M in the prior-year period — down 53.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORPH's current cash is now $14M (was $30M) — a 53.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Orphazyme A/S is outperforming or lagging.

Tracking ORPH's current cash over time shows whether Orphazyme A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $14M That compares with $30M in the prior-year period — down 53.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Orphazyme A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $14M) with ownership activity and broader fundamentals.

Orphazyme A/S's current cash is $14M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.